AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Motor Development and Early Predictors of Psychomotor Outcomes in Preterm and Term Infants Assessed by MOS-R and Caregiver Questionnaire at 18 and 36 Months

Recruitingn/aAges any - 3 YearsAllMasaryk University
💬

In plain words

What the trial is, and whether it could suit you

This study examines how early motor behavior in infants relates to their later psychomotor development. Researchers will observe both preterm and full-term infants during the first months of life, using video-based assessments to evaluate spontaneous movements and early postural control. These early motor patterns will be scored with the Motor Optimality Score - Revised (MOS-R). When the children reach 18 and 36 months of age, their development in areas such as motor skills, communication, sensory processing, and social behavior will be evaluated through a caregiver-completed questionnaire. The purpose of the study is to determine whether early motor quality can predict later developmental outcomes, whether preterm and full-term infants with similar motor scores develop differently, and whether early therapy may improve outcomes for infants with low MOS-R results.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * The child was born either preterm or full-term. Both groups are included in the study. * The child completed a video recording of early movements during routine check-ups in the first months of life. * The parents or legal guardians agree to participate and give informed consent. * The child will be available for follow-up at around 18-36 months of age, when parents will complete a developmental questionnaire. Exclusion Criteria: * There is no usable video recording of the child's early spontaneous movements from the neonatal or early infant period. * The child has a diagnosed medical condition that makes movement assessment impossible (for example, severe congenital anomalies or conditions preventing typical movement). * Parents do not wish to participate or withdraw their consent. * The child is not available for follow-up, meaning that the developmental questionnaire at 18-36 months cannot be completed.
💊

What it tests

  • Vojta method
📍

Where

3 sites
Nemocnice Pardubického kraje, a.s.
Pardubice, Czechia
Lentilka - integrated kindergarden and rehabilitation center
Pardubice, Czechia
Lentilka - integrated kindergarden and rehabilitation center
Pardubice, Czechia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy